“longitude-capital” Archives

in
Entry Author Date Location
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Bayer Boosts Women’s Health Drug Pipeline, Paying $425M for KaNDy 08/11/20 Europe
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round 04/22/19 San Diego
Tiburio Launches from Cydan with $31M to Tackle Pituitary Tumors 01/03/19 Boston
89Bio Joins NASH Chase with a Teva Drug and $60M in Funding 10/25/18 San Francisco
Inozyme Gets $49M From Sanofi, Novo to Tackle Rare Infant Disease 11/15/17 Boston
Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals 04/06/17 San Diego
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
Kala Pharma Nabs $68M, Crossover Backers for Eye Drug Push 04/13/16 Boston
Aimmune Prices Upsized $160M IPO, Climbs Higher in Debut 08/06/15 San Francisco
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More 03/13/15 San Francisco
Allergen Takes $80M Series B for Phase 3 Peanut Allergy Trial 03/12/15 San Francisco
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
Civitas Scores $38M Series B For Parkinson’s Drug Push 09/11/13 Boston
Alkermes Spinout, Civitas, Nabs Second Grant From Fox Foundation 06/18/13 Boston
Civitas Charts Positive Data on Inhaled Parkinson’s Drug 01/06/12 Boston
CardioDx Raises $60M 05/11/11 San Francisco
CardioDx Raises $40M 03/07/11 San Francisco
$12.7M Blows in for Wind Power Holdings, Epizyme Forges Alliance with GlaxoSmithKline, & Many More Boston-Area Deals 01/12/11 Boston
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout 01/10/11 Boston
$15M for Aptus Endosystems 08/31/10 San Francisco
Brightcove Bonds With AOL, Faces Competition With Akamai; Fidelity Backs EnVivo; Dyax to Sell Up To $50M in Stock; & More Boston-Area Deals News 11/03/08 Boston
Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News 10/29/08 Boston
HC Ventures Leads $28M Round for InfaCare 10/28/08 Boston
Page 1 of 1